Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Vivo Bio Tech Ltd has submitted a nil report to BSE regarding the re-lodgement of physical share transfer requests under a special window opened by SEBI circular dated January 30, 2026. The filing, prepared by the company's Registrar and Share Transfer Agent Aarthi Consultants Private Limited, confirms that for the month of April 2026, the company received zero requests, processed zero requests, approved zero requests, and rejected zero requests related to re-lodgement of physical share transfers. This is a routine regulatory compliance filing confirming no activity during the reported period.
No impact on shareholders as this is a nil-activity compliance report. The company is simply confirming it had no requests under the SEBI special re-lodgement window for physical share transfers.